secwatch.observer — SEC 8-K summary
======================================

Issuer:     RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK:        0001649904
Form:       8-K
Filed at:   2023-06-22T23:59:59+00:00
Accession:  0001104659-23-073809
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Rhythm Pharma annual meeting: all proposals approved by stockholders
--------------------------------------------------------------------

- 49,290,096 shares (~86.7%) present at June 21, 2023 meeting.
- Three Class III directors elected: Bedrosian, McGirr, Meeker with strong majorities.
- Ratification of Ernst & Young as auditor passed 49.2M for, 22k against.
- Advisory compensation vote approved 38.8M for, 1.9M against, 5.9M abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649904/000110465923073809/0001104659-23-073809-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649904/000110465923073809/tm2319441d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-073809

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer